Meta-Analysis of MMP2 -1306T Allele as a Protective Factor in Digestive Cancer

Archives of Medical Research

Volumn 42, Issue 3, 2011, Pages 239-243

  Zhang, Le yao ^a   Ren, Ke wei ^b  

^a Wuxi 9th People s Hospital Affiliated to Suzhou Medical College of Soochow University   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

1306T allele; Digestive cancer; MMP2; Polymorphism; Risk Meta analysis

Indexed keywords

GELATINASE A;

ALLELE; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; EMBASE; ESOPHAGUS CANCER; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MEDLINE; META ANALYSIS; MOUTH CANCER; SMOKING; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; GASTROINTESTINAL NEOPLASMS; GENETIC ASSOCIATION STUDIES; HUMANS; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79959691220     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.04.013     Document Type: Article

References (23)

1. Nagase H., Woessner J.F. Matrix metalloproteinases. J Biol Chem 1999, 274:21491-21494.
2. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Caner 2002, 2:161-174.
3. Qin H., Sun Y., Benveniste E.N. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 1999, 274:29130-29137.
4. Miao X., Yu C., Tan W., et al. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 2003, 63:3987-3990.
5. Levi E., Fridman R., Miao H.Q., et al. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci USA 1996, 93:7069-7074.
6. Price S.J., Greaves D.R., Watkins H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 2001, 276:7549-7558.
7. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000, 10:415-433.
8. Peter M.C., Pankaj S. Polymorphisms of matrix metalloproteinases 1,2,3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects. Int J Cancer 2009, 125:1473-1478.
9. Peng B., Cao L., Ma X., et al. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Mutagenesis 2010, 25:371-379.
10. Xu E.P., Huang Q., Lu B.J., et al. The correlation between polymorphisms of matrix metalloproteinase-2 and -9 genes and colorectal cancer of Chinese patients. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006, 23:78-81.
11. Xu E., Lai M., Lv B., et al. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer. Biochem Biophys Res Commun 2004, 324:999-1003.
12. Li Y., Sun D.L., Duan Y.N., et al. Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China. Mol Biol Rep 2010, 37:197-205.
13. Zhang X.M., Miao X.P., Xiong P., et al. Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population. Ai Zheng 2004, 23:1233-1237.
14. Kubben F., Sier C., Meijer M., et al. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer 2006, 95:744-751.
15. Yu C., Zhou Y., Miao X., et al. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res 2004, 64:7622-7628.
16. Chen X.B., Chen G.L., Liu J.N., et al. Genetic polymorphisms in STK15 and MMP-2 associated susceptibility to esophageal cancer in Mongolian population. Zhonghua Yu Fang Yi Xue Za Zhi 2009, 43:559-564.
17. Elander N., Söderkvist P., Fransén K. Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res 2006, 26:791-795.
18. Lin S.C., Lo S.S., Liu C.J., et al. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med 2004, 33:405-409.
19. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
20. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
21. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
22. Egger M., Davey Smith G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
23. Zeidel A., Beilin B., Yardeni I., et al. Immune response in asymptomatic smokers. Acta Anaesthesiol Scand 2002, 46:959-964.